Form 4: Aehr Test Systems CFO Executes Stock Sale

Sentiment:

Statement of Changes in Beneficial Ownership


CFO Chris Siu sold a total of 2,070 shares of Aehr Test Systems common stock on May 14, 2026.

Summary

  • Chris Siu, CFO of Aehr Test Systems, sold 470 shares of common stock at a price of $108.00 per share.
  • An additional 1,600 shares held in a trust were sold at an average price of $106.78 per share.
  • Following these transactions, the reporting person maintains a direct beneficial ownership of 70,270 shares, which includes unvested restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the filing reflects routine insider activity rather than a material change in company strategy or financial health.

Positives

  • The transaction represents a standard divestment by an executive rather than a signal of fundamental business distress.

Negatives

  • Insider selling can sometimes be perceived by the market as a lack of confidence in near-term price appreciation.

Risks

  • Market volatility affecting the valuation of equity-based compensation held by insiders.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this regulatory filing.

Industry Context

StockSavvy.ai notes that executive stock sales are common occurrences for liquidity or tax planning purposes and do not necessarily reflect a change in the company's operational trajectory or industry standing.

Comparison to Industry Standards

  • The sale of shares by a CFO is a routine corporate governance event consistent with standard executive compensation management across the semiconductor equipment industry.

Stakeholder Impact

  • Minimal impact on shareholders as the volume of shares sold is relatively small compared to total outstanding shares.

Next Steps

  • No future actions or milestones were disclosed in this filing.

Key Dates

DateDescription
05/14/2026Date of the reported stock sale transactions.
05/15/2026Date the Form 4 was signed and filed.

Keywords

Aehr Test Systems, AEHR, Insider Trading, Form 4, CFO, Stock Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.